We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
+12.63%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$748M
AUM Growth
+$129M
Cap. Flow
+$53.9M
Cap. Flow %
7.21%
Top 10 Hldgs %
26.08%
Holding
178
New
37
Increased
70
Reduced
44
Closed
16

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$11M
2
ABT icon
Abbott
ABT
+$10.3M
3
AAPL icon
Apple
AAPL
+$6.07M
4
SKX
Skechers
SKX
+$5.95M
5
MSFT icon
Microsoft
MSFT
+$5.03M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.18M
2
DXCM icon
DexCom
DXCM
+$5.55M
3
MFC icon
Manulife Financial
MFC
+$4.8M
4
THO icon
Thor Industries
THO
+$4.4M
5
EBAY icon
eBay
EBAY
+$4.13M

Sector Composition

Rank Sector Weight
1 Healthcare 30.41%
2 Technology 18.73%
3 Consumer Discretionary 15.44%
4 Financials 11.8%
5 Industrials 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.48T
$32.3M 4.32%
167,610
+32,901
+24% +$6.07M
MSFT icon
2
Microsoft
MSFT
$3.72T
$28.9M 3.86%
76,777
+14,127
+23% +$5.03M
UNH icon
3
UnitedHealth
UNH
$368B
$19.3M 2.58%
36,599
-5,890
-14% -$3.14M
IQV icon
4
IQVIA
IQV
$40B
$18.7M 2.51%
81,028
-6,825
-8% -$1.4M
SCI icon
5
Service Corp International
SCI
$11.4B
$17.1M 2.29%
250,000
-25,000
-9% -$1.51M
MFC icon
6
Manulife Financial
MFC
$73.1B
$16.7M 2.23%
754,270
-250,000
-25% -$4.8M
MRK icon
7
Merck
MRK
$321B
$15.7M 2.1%
144,324
+7,230
+5% +$750K
TMO icon
8
Thermo Fisher Scientific
TMO
$222B
$15.5M 2.08%
29,236
-6,112
-17% -$2.96M
BC icon
9
Brunswick
BC
$5.26B
$15.5M 2.07%
160,000
-15,000
-9% -$1.19M
LLY icon
10
Eli Lilly
LLY
$1.09T
$15.3M 2.05%
26,228
-3,524
-12% -$2.06M
AMZN icon
11
Amazon
AMZN
$2.93T
$15.1M 2.02%
99,308
+22,624
+30% +$3.17M
VRTX icon
12
Vertex Pharmaceuticals
VRTX
$134B
$14.7M 1.97%
36,127
-16,729
-32% -$6.18M
NVDA icon
13
NVIDIA
NVDA
$5.29T
$14.7M 1.96%
296,130
+32,300
+12% +$1.5M
EVH icon
14
Evolent Health
EVH
$481M
$13.2M 1.77%
400,000
+100,000
+33% +$2.83M
RMD icon
15
ResMed
RMD
$32.1B
$12.9M 1.73%
75,082
-172
-0.2% -$26.4K
ABT icon
16
Abbott
ABT
$190B
$12.6M 1.68%
114,243
+103,039
+920% +$10.3M
LH icon
17
Labcorp
LH
$26.2B
$11.7M 1.57%
51,495
-4,188
-8% -$880K
AMP icon
18
Ameriprise Financial
AMP
$49.7B
$11.6M 1.55%
30,482
-7,330
-19% -$2.51M
HOLX
19
DELISTED
Hologic
HOLX
$11.5M 1.54%
161,629
+778
+0.5% +$54.2K
TOL icon
20
Toll Brothers
TOL
$14.3B
$11.3M 1.51%
110,000
-30,000
-21% -$2.5M
MCK icon
21
McKesson
MCK
$104B
$11.2M 1.49%
+24,119
New +$11M
INMD icon
22
InMode
INMD
$871M
$11.1M 1.48%
499,000
-9,057
-2% -$203K
GL icon
23
Globe Life
GL
$14.2B
$11M 1.47%
90,000
-15,579
-15% -$1.83M
VRTS icon
24
Virtus Investment Partners
VRTS
$1.13B
$10.9M 1.46%
45,000
– –
OPCH icon
25
Option Care Health
OPCH
$3.66B
$10.8M 1.44%
320,000
+120,000
+60% +$3.69M
1
2 3 4 5

Similar funds

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
WCA
Waratah Capital Advisors Toronto, Ontario, Canada $2.63B AUM 76.33% 1-Year Est. Return
CCM
Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s Q4 2023 Portfolio in Review

As of Q4 2023, Lombard Odier Asset Management (Switzerland) held 178 positions worth $748M, up 21% from $618M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Lombard Odier Asset Management (Switzerland) deployed $53.9M of net new capital in Q4 2023, opening 37 new positions and adding to 70 existing holdings. Its largest new stake was McKesson: 24,119 shares worth $11.2M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.18M trimmed.

  • Lombard Odier Asset Management (Switzerland)'s largest Q4 2023 buy was McKesson: 24,119 shares worth $11.2M.
  • Lombard Odier Asset Management (Switzerland) added most to Abbott in Q4 2023, an estimated $10.3M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q4 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.18M.
  • Lombard Odier Asset Management (Switzerland) fully exited DexCom in Q4 2023, selling an estimated $5.55M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 26% of its $748M portfolio in Q4 2023.
  • Lombard Odier Asset Management (Switzerland) opened 37 new positions and closed 16 in Q4 2023.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value rose 21% quarter-over-quarter to $748M.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q4 2023, filed 14 Feb 2024.